PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA
- PMID: 9930876
- DOI: 10.1038/5607
PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasma-derived HIV-1 RNA
Abstract
A PCR-based approach was developed that provides a powerful tool for engineering recombinant molecules without reliance on restriction sites. DNA sequences were first amplified by high-fidelity PCR using Pfu polymerase; they were then used both as 'megaprimers' and templates in subsequent asymmetric long PCR amplifications to form chimeric clones. To demonstrate the technique, we constructed chimeric full-length HIV-1 clones derived from reverse-transcribed plasma viral RNA and proviral LTRs. Biologic characterization of these clones showed that most were infectious in tissue culture and sequence analysis demonstrated an error rate of only one base change in 20 kb of DNA sequence. For PCR-mediated recombination, it is necessary to know the sequence of the 3' and 5' overlapping regions of the desired PCR products. This method may be extended to include construction of chimeras between any DNA fragments lacking sequence homology. Such chimeras may be constructed by introducing overlapping sequences to one of the fragments. To ensure that unwanted mutations have not been introduced into the clones constructed by this method, each clone should be sequenced. Our results demonstrate that by using a high-fidelity polymerase and highly controlled PCR conditions, the PCR-introduced error rate can be greatly minimized. This new procedure may be used to construct infectious chimeras of HIV or SIV for studies of vaccines and pathogenesis. Moreover, the method is designed to exchange viral genes at precise boundaries to study individual gene products from different HIV genomes. It can also be used to construct expression vectors for production of specific proteins or delivery vectors for gene transfer and gene therapy. Finally, the technique described here provides a versatile tool to transfer genes or gene fragments from different sources for genetic investigation and engineering.
Similar articles
-
PCR amplification, cloning, and construction of HIV-1 infectious molecular clones from virtually full-length HIV-1 genomes.Methods Mol Biol. 2005;304:387-98. doi: 10.1385/1-59259-907-9:387. Methods Mol Biol. 2005. PMID: 16061991
-
Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR.Virology. 1995 Dec 20;214(2):611-8. doi: 10.1006/viro.1995.0072. Virology. 1995. PMID: 8553563
-
Chimeric gene library construction by a simple and highly versatile method using recombination-dependent exponential amplification.Biotechnol Prog. 2003 Sep-Oct;19(5):1460-7. doi: 10.1021/bp034029t. Biotechnol Prog. 2003. PMID: 14524707
-
[Successes and prospects for genetic engineering].Genetika. 1976;12(7):150-73. Genetika. 1976. PMID: 63407 Review. Russian.
-
[Advances in Molecular Cloning].Mol Biol (Mosk). 2016 Jan-Feb;50(1):3-9. doi: 10.7868/S0026898416010134. Mol Biol (Mosk). 2016. PMID: 27028806 Review. Russian.
Cited by
-
Loss of the protease dimerization inhibition activity of tipranavir (TPV) and its association with the acquisition of resistance to TPV by HIV-1.J Virol. 2012 Dec;86(24):13384-96. doi: 10.1128/JVI.07234-11. Epub 2012 Sep 26. J Virol. 2012. PMID: 23015723 Free PMC article.
-
Amino acid insertions near Gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors.J Virol. 2004 Nov;78(21):12030-40. doi: 10.1128/JVI.78.21.12030-12040.2004. J Virol. 2004. PMID: 15479842 Free PMC article. Clinical Trial.
-
Early phase dynamics of traceable mCherry fluorescent protein-carrying HIV-1 infection in human peripheral blood mononuclear cells-transplanted NOD/SCID/Jak3-/- mice.Antiviral Res. 2017 Aug;144:83-92. doi: 10.1016/j.antiviral.2017.03.027. Epub 2017 Apr 7. Antiviral Res. 2017. PMID: 28392419 Free PMC article.
-
Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.J Virol. 2000 Nov;74(22):10612-22. doi: 10.1128/jvi.74.22.10612-10622.2000. J Virol. 2000. PMID: 11044105 Free PMC article.
-
Mechanism of Darunavir (DRV)'s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance.mBio. 2018 Mar 6;9(2):e02425-17. doi: 10.1128/mBio.02425-17. mBio. 2018. PMID: 29511083 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases